Recent Articles
How Atypical PKCζ Regulates Path...
Roles of Serine/Threonine Phosph...
Histone Crotonylation: Reshaping...
TRIM21 as a Central Determinant for Anti‑Tau Immunotherapy Efficacy: Mechanis...
This neurodegeneration‑immunology review interprets cytosolic Fc‑receptor TRIM21‑dependent intracellular tau‑aggregate clearance for anti‑tau passive‑immunotherapy, P301S tau‑transgenic / OHSC / hiPSC‑neuron experimental‑model outputs and p‑Tau212 (T212) biomarker‑therapeutic‑target characteristics. It provides phospho‑Tau (T212)...
TRIM21 as a Central Determinant for Anti‑Tau Immunotherapy Efficacy: Mechanis...
This neurodegeneration‑immunology review interprets cytosolic Fc‑receptor TRIM21‑dependent intracellular tau‑aggregate clearance for anti‑tau passive‑immunotherapy, P301S tau‑transgenic / OHSC / hiPSC‑neuron experimental‑model outputs and p‑Tau212 (T212) biomarker‑therapeutic‑target characteristics. It provides phospho‑Tau (T212)...
Read More
Innovative Directions for Modern Biopharma Antibody‑Discovery and Antibody‑En...
This biopharma‑R&D review analyses innovative antibody‑drug development directions covering ADC, multispecific‑antibodies, antibody‑fragments, nanobodies and antibody‑cytokine‑fusion‑proteins. It introduces end‑to‑end industrial‑grade custom antibody‑discovery service from ANT BIO PTE. LTD for target‑validation, lead‑candidate‑screening,...
Innovative Directions for Modern Biopharma Antibody‑Discovery and Antibody‑En...
This biopharma‑R&D review analyses innovative antibody‑drug development directions covering ADC, multispecific‑antibodies, antibody‑fragments, nanobodies and antibody‑cytokine‑fusion‑proteins. It introduces end‑to‑end industrial‑grade custom antibody‑discovery service from ANT BIO PTE. LTD for target‑validation, lead‑candidate‑screening,...
Read More
PTEN Tumour‑Suppressor: Decoding Gene‑Inactivation Mechanisms for Pre‑Clinica...
This oncology‑biology review explains PTEN tumour‑suppressor molecular functions, PI3K‑AKT‑mTOR / MAPK / FAK signalling‑axis regulation, PTEN‑loss‑driven therapeutic‑resistance to immune‑checkpoint‑blockade and pre‑clinical combination‑treatment research. It lists PTEN‑series recombinant rabbit mAbs (S0B2105,...
PTEN Tumour‑Suppressor: Decoding Gene‑Inactivation Mechanisms for Pre‑Clinica...
This oncology‑biology review explains PTEN tumour‑suppressor molecular functions, PI3K‑AKT‑mTOR / MAPK / FAK signalling‑axis regulation, PTEN‑loss‑driven therapeutic‑resistance to immune‑checkpoint‑blockade and pre‑clinical combination‑treatment research. It lists PTEN‑series recombinant rabbit mAbs (S0B2105,...
Read More
Phosphorylated PLCγ1 (Tyr783): Regulating Liquid‑Liquid Phase Separation With...
This adaptive‑immunology signalling review interprets liquid‑liquid phase separation (LLPS) of LAT signalling condensates, dual enzymatic‑scaffold functions of PLCγ1, SH2‑domain‑mediated LAT cross‑linking, CD45‑dephosphorylation shielding and non‑monotonic concentration‑dependent LLPS regulation. It features...
Phosphorylated PLCγ1 (Tyr783): Regulating Liquid‑Liquid Phase Separation With...
This adaptive‑immunology signalling review interprets liquid‑liquid phase separation (LLPS) of LAT signalling condensates, dual enzymatic‑scaffold functions of PLCγ1, SH2‑domain‑mediated LAT cross‑linking, CD45‑dephosphorylation shielding and non‑monotonic concentration‑dependent LLPS regulation. It features...
Read More
PIK3CG (p110γ): Uncovering Potential Targets for Mechanistic Studies of Sepsi...
This inflammation‑cardiology review interprets multi‑omics identification of PIK3CG (p110γ) as hub gene in sepsis‑triggered myocardial injury, dual inflammatory‑cardioprotective functions of PI3Kγ, melatonin‑PIK3CG molecular‑docking findings and pre‑clinical animal‑model observations. It provides...
PIK3CG (p110γ): Uncovering Potential Targets for Mechanistic Studies of Sepsi...
This inflammation‑cardiology review interprets multi‑omics identification of PIK3CG (p110γ) as hub gene in sepsis‑triggered myocardial injury, dual inflammatory‑cardioprotective functions of PI3Kγ, melatonin‑PIK3CG molecular‑docking findings and pre‑clinical animal‑model observations. It provides...
Read More
Leveraging GFP‑Fusion Tags and Anti‑GFP Nanobody Beads for Diverse Target‑Pro...
This molecular‑cell‑biology review covers intrinsic structural features of GFP/EGFP fluorescent tags, anti‑GFP nanobody agarose‑magnetic bead working principles, Co‑IP, GFP‑ChIP, interactome‑proteomics workflows, experimental advantages of VHH‑based affinity resin. It presents Anti‑GFP...
Leveraging GFP‑Fusion Tags and Anti‑GFP Nanobody Beads for Diverse Target‑Pro...
This molecular‑cell‑biology review covers intrinsic structural features of GFP/EGFP fluorescent tags, anti‑GFP nanobody agarose‑magnetic bead working principles, Co‑IP, GFP‑ChIP, interactome‑proteomics workflows, experimental advantages of VHH‑based affinity resin. It presents Anti‑GFP...
Read More